According to Redhill Biopharma's latest financial reports the company has NZ$12.46 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | NZ$31.47 M | -43.43% |
2021-12-31 | NZ$55.63 M | 34.75% |
2020-12-31 | NZ$41.29 M | -41.91% |
2019-12-31 | NZ$71.08 M | -10.35% |
2018-12-31 | NZ$79.28 M | 21.87% |
2017-12-31 | NZ$65.05 M | -31.88% |
2016-12-31 | NZ$95.5 M | 12.43% |
2015-12-31 | NZ$84.94 M | 190.07% |
2014-12-31 | NZ$29.28 M | 98.67% |
2013-12-31 | NZ$14.74 M | -33.97% |
2012-12-31 | NZ$22.32 M | -6.56% |
2011-12-31 | NZ$23.89 M |